Aethlon Medical, Inc.
Steven P Larosa (Chief Medical Officer) reports AEMD insider transactions
About this filing
Aethlon Medical, Inc. (AEMD) filed Form 4 (insider transaction) with the SEC on Oct 15, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Steven P Larosa · Chief Medical Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | A · grantFootnotes F1 | +42,000 | $0.00 | $0.00 | 42,057 | Direct |
Footnotes
- F1 Represents a grant of 42,000 restricted stock units ("RSUs") pursuant to the Issuer's 2020 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest over the one-year period following October 8, 2026, subject to the Reporting Person's continued service through the applicable vesting dates. Notwithstanding the foregoing, the RSUs will become fully vested upon the closing of the Issuer's proposed merger with North Immunology, Inc.
More AEMD filings
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- S-8
Filed Nov 12, 2026
- 4
Filed Oct 15, 2026
- 4/A
Filed Oct 15, 2026
- 4
Filed Oct 15, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.